Brian Pilcher, PhD Appointed as Chief Scientific Officer at Suneva Medical
SAN DIEGO, March 28, 2019 /PRNewswire/ -- Suneva® Medical, Inc., privately held aesthetics company, announces the appointment of Chief Science Officer, Brian Pilcher PhD.
Dr. Brian K. Pilcher joins Suneva Medical with over 18 years of experience in Dermatology and Aesthetics, most recently as Principal of Critical MASS Scientific Strategy Consultants, where he worked to develop programs in support of established product life cycle and new product launches, as well as medical affairs and clinical education activities. He also served as Vice President of Medical Affairs for Merz North America, Vice President of Medical Affairs and Clinical Education for BioForm Medical, and Director of Research for Cutanix Corporation.
In each of these roles, Dr. Pilcher has leveraged his unique combination of scientific and commercial expertise to direct and implement innovative and effective medical and clinical communications platforms and lead medical affairs teams in developing strong relationships with both thought leaders and the broader medical community. Leading a team of 40 nurse and physician assistant educators whose goal was to ensure optimal clinical results, Dr. Pilcher has developed novel educational initiatives to ensure safe and effective uses of drugs and medical devices, while focusing on the highest standards of patient safety and satisfaction.
Dr. Pilcher earned his PhD in Anatomy and Cell Biology from the University Of Oklahoma College Of Medicine. He completed his post-graduate training in Dermatology at Washington University in St. Louis, and served as an Assistant Professor at University of Texas Southwestern Medical Center in the Department of Cell Biology where his research focus was on the cellular and molecular mechanisms of wound repair.
"I am honored and excited to join the Suneva Medical team as we enter into the company's next phase of becoming a leader in regenerative aesthetics," said Pilcher. "I am confident that by building a strong scientific and clinical platform we will take the brand and new and current portfolio of products to the next level."
About Suneva Medical, Inc.
Suneva Medical is a privately‐held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the aesthetic markets. The innovative aesthetics leader markets Bellafill®, the only dermal filler on the market that is approved by the U.S. Food and Drug Administration for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years old. The company markets Bellafill® in the U.S., Canada, Hong Kong, Korea and Mexico. For more information, visit www.sunevamedical.com.
SOURCE Suneva Medical, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article